Gene Query: PC

Dataset Description Geneva Score
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 58.83
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 58.83
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 57.2
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 43.43
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 39.67
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 39.67
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 38.57
Rorc disruption in human FG pancreatic cancer cells 38.21
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 37.58
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 37.56
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 36.75
Global analyses of the effect of different cellular contexts on microRNA targeting 36.75
Cleavage Factor Im as a key regulator of 3’ UTR length 33.8
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 30.49
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  29.96
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 29.85
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 29.18
MOF acetyl transferase regulates transcription and respiration in mitochondria 27.45
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 27.38
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 27.0
Genome-wide identification of cancer-specific alternative splicing in circRNA 26.94
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 26.41
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 26.2
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 25.78
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 25.59
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 25.59
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 25.57
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 25.17
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 24.83
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 24.22
Cajal bodies are linked to genome conformation [RNA-Seq] 23.66
Cajal bodies are linked to genome conformation 23.66
SUV420H2 knockdown in PANC-1 23.07
The expression profiles of GBC liver metastasis 22.91
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 21.97
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 21.37
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 20.62
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.19
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 19.83
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 19.72
Silencing p300 in MCF7 cells to study expression and alternative splicing 19.02
Single-nucleotide-resolution mapping of HBV promoters using CAGE 18.84
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 18.74
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 18.39
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 18.21
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 18.03
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 17.68
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  17.66
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 17.39
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 16.92
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 16.77
Transcriptomic profile of human embryonic renal corpuscles 16.52
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 16.52
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 16.38
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 16.28
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 16.07
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 15.71
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 15.71
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 15.34
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 15.31
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 15.24
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 14.89
Exploring ILF2 regulatory genes by next-generation sequencing 14.87
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 14.37
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 14.37
H1609088 Human RNA-Sequencing 14.33
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.19
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 13.87
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 13.75
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 13.66
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 13.65
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 13.62
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 13.54
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 13.45
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 13.4
PGE2 mediated gene expression changes in human cervical stromal cells 13.37
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 13.22
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 13.16
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 13.16
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 13.13
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 13.13
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 13.13
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 13.04
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 13.04
Genome wide expression change by RNF168 knocking down in MCF-7 cells 12.98
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.98
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.98
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 12.96
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 12.96
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 12.8
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 12.8
Regulation of Lipids is Central to Replicative Senescence 12.61
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.56
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.56
RNA-seq in HepG2 and IMR90 cells 12.24
Evolution of a transcriptional regulator from a transmembrane nucleoporin 12.24
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 12.22
Molecular analysis of renal cell carcinoma with unclassfied histology 12.19
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 12.19
CHD1 regulates cell fate determination by activation of differentiation-induced genes 12.15
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 12.06
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 12.03
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 12.03
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 11.9
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 11.9
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 11.83
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 11.82
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.79
Comparing gene expression in iPSC derived RPE from control and AMD donors 11.77
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 11.57
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 11.5
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 11.47
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 11.43
Chromatin landscape of human visceral and subcutaneous adipocytes 11.41
Transcriptome analysis of U87 cells upon LINC00152 knockdown 11.25
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 11.22
Accurate annotation of human protein-coding small open reading frames 11.19
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 11.11
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 11.01
An RNA-centric dissection of host complexes controlling flavivirus infection 10.95
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 10.95
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.86
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.86
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 10.79
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 10.72
Fbxo32 mediated gene expression program underlies EMT and metastasis 10.71
Effect of Hotair overexpression in human breast cancer cell lines 10.7
Genome wide expression change by RNF168 knocking down in NEC cells 10.7
LNCaP treated with iBET 10.63
Transcriptome of human white and brown adipose tissue biopsies 10.62
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 10.62
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 10.62
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 10.61
Genome wide expression change in LCC2 and MCF-7 cells 10.54
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 10.44
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 10.42
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 10.42
Gene expression analysis of human liver progenitor-like cells in culture 10.27
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 10.22
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 10.19
Selective expression of long non-coding RNAs in a breast cancer cell progression model 10.18
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 10.06
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 10.0
Gene expression analysis of the impact of TDP-43 knockout in human cells. 9.99
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 9.98
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 9.79
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 9.76
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.74
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 9.72
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.63
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 9.63
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.61
Inhibition of TNBC metastasis by Gpx1 9.59
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 9.54
Downregulation of DDX5/DDX17 and REST 9.51
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 9.48
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 9.48
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 9.44
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.44
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 9.41
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.35
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 9.32
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 9.31
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.25
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 9.24
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.2
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 9.15
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 9.14
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 9.12
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 9.08
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 9.07
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 9.06
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 9.05
RNA-seq of tumor cells following angiopellosis extravasation 9.0
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 8.98
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 8.92
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 8.92
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 8.85
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 8.75
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 8.7
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 8.61
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 8.61
LIN28A modulates splicing and gene expression programs in breast cancer cells 8.61
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 8.59
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 8.52
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 8.4
Global epigenomic reconfiguration during mammalian brain development 8.39
Transcriptomic analysis of LSD1 8.34
Hepatocyte maturation 8.33
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 8.32
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 8.32
Regulation of poly(A) tail and translation during the somatic cell cycle 8.25
LIN28A Over-expression RNAseq 8.23
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 8.13
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 8.1
Downregulation of LATS kinases alters p53 to promote cell migration 8.09
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 7.99
Differential Gene Expression between MCF10A and MCF7 cells 7.96
MCF10A H-Ras RNA-Seq 7.89
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.83
The MEF2B Regulatory Network 7.82
The MEF2B Regulatory Network - RNA-seq data 7.82
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 7.81
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 7.8
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 7.78
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 7.77
DRB/GRO-Seq -/+ UV 7.75
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 7.72
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 7.7
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 7.69
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.61
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 7.49
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 7.49
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.48
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 7.44
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 7.4
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.39
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 7.38
RNA sequencing of human pancreatic cancer cell lines 7.32
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.31
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.3
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.3
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 7.29
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 7.17
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 7.17
RNAseq of T-ALL upon long non coding rna purturbation 7.16
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 7.15
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.15
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.12
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 7.07
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.05
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.98
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 6.97
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.93
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 6.91
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 6.89
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 6.89
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.87
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 6.85
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 6.85
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.79
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.79
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 6.73
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 6.73
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 6.73
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.68
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 6.59
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 6.53
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.51
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.51
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 6.48
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.47
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.47
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 6.33
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 6.32
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.3
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.29
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 6.28
RNA-seq of MDA-MB-231 cells with TET1 knockout 6.27
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.22
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 6.2
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.14
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 6.13
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.09
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.09
G-quadruplex structures mark human regulatory chromatin 6.09
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 6.05
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 6.04
Hepatitis C virus functionally sequesters miR-122 6.04
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.02
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 5.98
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.91
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.91
Energy Metabolism during Anchorage-Independence 5.88
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.87
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.87
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 5.81
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.76
Trans-differentiation of human adult peripheral blood T cells into neurons 5.74
X-Ray induced DNA-Hydroxymethylation changes 5.74
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 5.71
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.69
Gene expression patterns define the hepatocyte-like cells derived by different strategies 5.69
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 5.69
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.65
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.61
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.61
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 5.6
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 5.59
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.58
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 5.5
Transcriptomic analysis of ERR alpha orphan nuclear receptor 5.43
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 5.43
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.42
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.42
RNA-seq of MCF10A cells and CAF 5.41
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.41
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.28
Expression patterns in chronic thromboembolic pulmonary hypertension 5.27
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 5.23
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.22
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 5.22
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 5.2
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.18
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 5.12
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.02
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.98
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.95
Gene expression profiling of papillary thyroid cancer from central and invasive regions 4.92
Gene expression analysis in response to hypoxic pathway inhibition 4.91
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 4.71
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 4.67
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 4.67
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.62
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 4.54
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.52
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 4.49
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.44
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.44
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.43
Gene expression profile difference among renal location in a stone former 4.41
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.4
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.39
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 4.38
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.36
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 4.36
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 4.36
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.33
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.33
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 4.29
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.29
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.26
Iron response of HepG2 cells 4.26
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 4.23
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.22
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.22
Impact on erythroid progenitor type on erythroid differntiation 4.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 4.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 4.2
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.17
Identification of Sin3B regulated genes during quiescence 4.15
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.1
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.08
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.05
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.99
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.93
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.93
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.87
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.8
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 3.76
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.73
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.72
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.69
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 3.66
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 3.66
Argonaute proteins couple chromatin silencing to alternative splicing 3.64
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.64
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.64
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.6
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.6
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.57
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 3.55
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.49
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.49
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.49
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.48
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.47
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.36
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 3.32
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 3.32
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 3.25
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.24
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 3.15
Gene expression analysis of human hepatocellular cancers 3.15
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.14
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 3.14
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.12
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.11
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.05
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 3.03
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.99
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.98
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 2.93
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.9
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.81
Trascriptome of thyroid cancer-induced macrophages 2.79
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.77
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 2.75
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.7
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.64
Differential gene expression in Jagged1 treated human dental pulp cells. 2.54
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.54
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.53
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 2.52
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.47
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.43
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.43
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.41
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.41
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.4
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.38
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.36
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 2.3
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.26
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.25
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.23
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.17
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.13
Gene expression changes due to PARP knockdown in human cells 2.05
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 1.99
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 1.92
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.91
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.89
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.89
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.88
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.88
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.73
The circadian transcriptional landscape in primary human mammary epithelial cells 1.72
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.69
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.69
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.68
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.67
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.65
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.65
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.63
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.63
Macrophage Ad5f35 PhenoMap 1.61
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.55
Characterization of parental and rociletinib-resistant derived H1975 cell lines 1.54
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.53
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.49
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.49
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.49
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.46
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.45
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.45
Gene profiling of human adult and pediatric liver cancer cells 1.44
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.39
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 1.37
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.3
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.3
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.3
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.3
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.2
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.18
Human optic chiasm from healthy controls and multiple sclerosis patients 1.16
Multiple sclerosis and EAE 1.16
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.14
RNA-sequencing of healthy human skeletal myocytes 1.09
Gene expression profile in breast cancer cells 1.08
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.08
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.05
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.05
RNA sequencing of mechanically strained NHEKs and control NHEKs 1.03
RNAseq analysis of ruxolitinib treated breast cancers 0.89
CSL RNA-Seq on HKC and SCC cell lines 0.86
CSL 0.86
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.8
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.79
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.79
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.79
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.79
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.69
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.64
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.56
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.56
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.52
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.5
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.5
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.49
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.49
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.46
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.45
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.45
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.45
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.44
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.44
Gene expression of collecting duct carcinoma of the kidney 0.36
RNA-seq of cancer cell lines treated with T-025 0.32
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.31
RNA-Seq and expression data from human adipose tissue 0.29
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.29
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.28
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.27
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.27
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.25
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.23
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.23
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.19
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.15
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.15
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.15
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 0.12
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.07
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.07
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.07
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.04
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation